Unlike CTLs, TCMNPs were free from immunosuppressive cytokines and PD-L1 on cancer cells by blocking TGF-β1 and PD-L1 via TGF-β1 receptors or PD-1 proteins on TCMNPs, which ultimately restored the cytotoxic functions of exhausted T cells. The gene discussed is CD274; the disease is cancer.